Skip to main content
Erschienen in: Journal of Natural Medicines 2/2018

08.02.2018 | Original Paper

Inhibitory effect of bofutsushosan (fang feng tong sheng san) on glucose transporter 5 function in vitro

Erschienen in: Journal of Natural Medicines | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Bofutsushosan (BTS; fang feng tong sheng san in Chinese) is a formula in traditional Japanese Kampo medicine and Chinese medicine comprising eighteen crude drugs, and is used to treat obesity and metabolic syndrome. Fructose is contained in refreshing beverages as high-fructose corn syrup, and is associated with obesity. Fructose is absorbed via glucose transporter 5 (GLUT5) in the intestine. Therefore, the inhibition of GLUT5 is considered to be a target of obesity drugs. We evaluated the inhibitory effects of BTS extract and its constituents on fructose uptake using Chinese hamster ovary K1 cells, i.e., cells stably expressing GLUT5. Boiled water extract of BTS significantly suppressed GLUT5 function in a concentration-dependent manner without cytotoxicities. Among 18 components of BTS, the boiled water extracts of the rhizome of Zingiber officinale, the root and rhizome of Saposhnikovia divaricata, and the root of Platycodon grandiflorum exhibited significant inhibitory effects on fructose uptake with IC50 values of 314, 119 and 475 µg/ml, respectively. Among the constituents of the rhizome of Z. officinale extract, 6-gingerol significantly inhibited GLUT5 with an IC50 value of 39 µM, while 6-shogaol exhibited a significant but weak inhibition on GLUT5 at 100 µM. One of the mechanisms of action of BTS may be the inhibition of fructose absorption in the intestine, and one of the active components of BTS is the rhizome of Z. officinale and 6-gingerol.
Literatur
1.
Zurück zum Zitat Pharmaceutical and Medical Device Regulatory Science Society of Japan (2016) Japanese pharmacopoeia (JP XVII), 17th edn. Jiho, Tokyo Pharmaceutical and Medical Device Regulatory Science Society of Japan (2016) Japanese pharmacopoeia (JP XVII), 17th edn. Jiho, Tokyo
2.
Zurück zum Zitat Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S (2013) Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity. PLoS One 8:e75560CrossRefPubMedPubMedCentral Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S (2013) Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity. PLoS One 8:e75560CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Park J, Bose S, Hong SW, Lee DK, Yoo JW, Lim CY, Lee M, Kim H (2014) Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3′UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. J Med Food 17:558–570CrossRefPubMedPubMedCentral Park J, Bose S, Hong SW, Lee DK, Yoo JW, Lim CY, Lee M, Kim H (2014) Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3′UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. J Med Food 17:558–570CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lin CH, Kuo YH, Shih CC (2014) Effects of Bofu–Tsusho–San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int J Mol Sci 15:20022–20044CrossRefPubMedPubMedCentral Lin CH, Kuo YH, Shih CC (2014) Effects of Bofu–Tsusho–San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int J Mol Sci 15:20022–20044CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Qian W, Hasegawa J, Tsuno S, Endo Y, Matsuda A, Miura N (2014) Effects of kampo formulas on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. Yonago Acta Med 57:147–158PubMedPubMedCentral Qian W, Hasegawa J, Tsuno S, Endo Y, Matsuda A, Miura N (2014) Effects of kampo formulas on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. Yonago Acta Med 57:147–158PubMedPubMedCentral
7.
8.
9.
Zurück zum Zitat Wright EM, Martin MG, Turk E (2003) Intestinal absorption in health and disease − sugars. Best Pract Res Clin Gastroenterol 17:943–956CrossRefPubMed Wright EM, Martin MG, Turk E (2003) Intestinal absorption in health and disease − sugars. Best Pract Res Clin Gastroenterol 17:943–956CrossRefPubMed
10.
11.
Zurück zum Zitat Barone S, Fussell SL, Singh AK, Lucas F, Xu J, Kim C, Wu X, Yu Y, Amlal H, Seidler U, Zuo J, Soleimani M (2009) Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem 284:5056–5066CrossRefPubMedPubMedCentral Barone S, Fussell SL, Singh AK, Lucas F, Xu J, Kim C, Wu X, Yu Y, Amlal H, Seidler U, Zuo J, Soleimani M (2009) Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem 284:5056–5066CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Japan Kampo Medicines Manufacturers Association under the supervision of National Institute of Health Sciences, the affiliated institutions of the Ministry of Health, Labour and Welfare of Japan (2013) Handbook on OTC Medicinal Products in Kampo. Jiho Japan Kampo Medicines Manufacturers Association under the supervision of National Institute of Health Sciences, the affiliated institutions of the Ministry of Health, Labour and Welfare of Japan (2013) Handbook on OTC Medicinal Products in Kampo. Jiho
14.
Zurück zum Zitat Oji I, Yamamoto N, Totsuka M, Satsu H (2015) Development and analysis of evaluation system to search for food factors that modulate fructose transporter in intestinal epithelia. The 12th Asian Congress of Nutrition: ACN2015, May 14–18, Yokohama, Japan. OS19-13, p 151 (Abstract) Oji I, Yamamoto N, Totsuka M, Satsu H (2015) Development and analysis of evaluation system to search for food factors that modulate fructose transporter in intestinal epithelia. The 12th Asian Congress of Nutrition: ACN2015, May 14–18, Yokohama, Japan. OS19-13, p 151 (Abstract)
15.
Zurück zum Zitat Semwal RB, Semwal DK, Combrinck S, Viljoen AM (2015) Gingerols and shogaols: important nutraceutical principles from ginger. Phytochemistry 117:554–568CrossRefPubMed Semwal RB, Semwal DK, Combrinck S, Viljoen AM (2015) Gingerols and shogaols: important nutraceutical principles from ginger. Phytochemistry 117:554–568CrossRefPubMed
17.
Zurück zum Zitat McKay DL, Blumberg JB (2006) A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 20:519–530CrossRefPubMed McKay DL, Blumberg JB (2006) A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 20:519–530CrossRefPubMed
Metadaten
Titel
Inhibitory effect of bofutsushosan (fang feng tong sheng san) on glucose transporter 5 function in vitro
Publikationsdatum
08.02.2018
Erschienen in
Journal of Natural Medicines / Ausgabe 2/2018
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-018-1183-0

Weitere Artikel der Ausgabe 2/2018

Journal of Natural Medicines 2/2018 Zur Ausgabe